Table 2.
Characteristics of secondary squamous cell carcinoma of head and neck in the survivors of hematopoietic stem cell transplantation for hematologic malignancies (comparing our series with series from literature review)
| Study | N | Oral cGvHD % | Prior dysplasia % | Multifocal/ metachronous SCC% | Tongue primary % | Median time from HSCT (years) | Risk factors (% of patients with alcohol use/tobacco use and HPV positivity) | Treatment | Recurrence % |
|---|---|---|---|---|---|---|---|---|---|
| Mawardi et al. [6] | 15 | 96 | 19 | 28 | 56 | 6 | 4/15/NR | Surgery alone 67% | 44 at median of 17 months |
| Chung et al. [7] | 7 | 100 | NR | 33 | 100 | 8 | 0/0/NR | 33 | |
| Chen et al. [8] | 6 | 100 | NR | None | 50 | 10 | 0/0/0 | NR | None at median of 3 years |
| Our series | 6 | 83 | 67 | 67 | 83 | 8 | 0/0/0 | Surgery alone 83% | 50 |
| Janin et al. [9] | 4 | 100 | NR | NR | NR | 5–22 | 0/0/NR | Surgery alone 100% | All died of recurrence by 1 year |
| Jaguar et al. [11] | 2 | 100 | NR | NRp | 50 | 13 and 15 years | 0/0/NR | Surgery and radiation | No recurrence at 2 years |
| Reddy et al. [12] | 3 | 33 | NR | NR | 33 | 1.5 years, 8 years, and 15 years | 0/0/NR | Surgery alone | 33 |
| Szeto et al. [13] | 2 | 100 | NR | NR | 100 | 2 and 6 years | 0/0/NR | Surgery alone | 50 |
cGvHD chronic graft-versus-host disease; NR not reported